Latanoprost Solution/ Drops

Latanoprost Solution/ Drops

Latanoprost Solution/ Drops Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Latanoprost Ophthalmic Solution, 0.005% has been reported to cause changes to pigmented tissues. The most frequently reported changes have been increased pigmentation of the iris, periorbital tissue (eyelid) and eyelashes, and growth of eyelashes. Pigmentation is expected to increase as long as Latanoprost Ophthalmic Solution, 0.005% is administered. After discontinuation of Latanoprost Ophthalmic Solution, 0.005%, pigmentation of the iris is likely to be permanent while pigmentation of the periorbital tissue and eyelash changes have been reported to be reversible in some patients. Patients who receive treatment should be informed of the possibility of increased pigmentation. The effects of increased pigmentation beyond 5 years are not known.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Latanoprost Ophthalmic Solution, 0.005% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.


There is currently no drug history available for this drug.

Other Information

Latanoprost is a prostaglandin F analogue. Its chemical name is isopropyl-(Z)-7 [(1R,2R,3R,5S) 3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate. Its molecular formula is C26H40O5 and Its chemical structure is:

Chemical Structure

Latanoprost is a colorless to slightly yellow oil that is very soluble in acetonitrile and freely soluble in acetone, ethanol, ethyl acetate, isopropanol, methanol and octanol. It is practically insoluble in water.

Latanoprost Ophthalmic Solution, 0.005% is supplied as a sterile, isotonic, buffered aqueous solution of latanoprost with a pH of approximately 6.7 and an osmolality of approximately 267 mOsmol/kg. Each mL of Latanoprost Ophthalmic Solution, 0.005% contains 50 micrograms of latanoprost. Benzalkonium chloride, 0.02% is added as a preservative. The inactive ingredients are: sodium chloride, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous and water for injection. One drop contains approximately 1.5 μg of latanoprost.

Latanoprost Solution/ Drops Manufacturers

  • Mwi
    Latanoprost Solution/ Drops [Mwi]
  • Physicians Total Care, Inc.
    Latanoprost Solution/ Drops [Physicians Total Care, Inc.]
  • Rebel Distributors Corp
    Latanoprost Solution/ Drops [Rebel Distributors Corp]
  • Bausch & Lomb Incorporated
    Latanoprost Solution/ Drops [Bausch & Lomb Incorporated]
  • Akorn, Inc.
    Latanoprost Solution/ Drops [Akorn, Inc.]
  • Remedyrepack Inc.
    Latanoprost Solution/ Drops [Remedyrepack Inc. ]

Login To Your Free Account